FindTrial
Sign In

The ratio of ascites-serum tumor markers in the differentiation of benign ascites from malignant ascites

The ratio of ascites-serum tumor markers in the differentiation of benign ascites from malignant ascites

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070820
Enrollment
Unknown
Registered
2023-04-24
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ascites

Interventions

benign ascites and malignant ascites :None

Sponsors

Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients with a clinical diagnosis of ascites.

Exclusion criteria

Exclusion criteria: Case information is incomplete, the cause of ascites is unknown, and the cause of ascites is portal hypertension with malignancy

Design outcomes

Primary

MeasureTime frame
ascites tumor markers;serum tumor markers;—

Countries

China

Contacts

Public ContactYuhu Song

Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology y

yuhusong@163.com+86 15007187581

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026